Last updated: February 13, 2026
What Are the Patentability Requirements for Biopharmaceuticals in Turkey?
Biopharmaceutical patents in Turkey must satisfy three main criteria: novelty, inventive step, and industrial applicability. The Turkish Patent Law (Law No. 551) aligns with international standards, such as the TRIPS agreement, but includes specific provisions for biotechnological inventions.
Novelty: The invention must not be disclosed before the filing date, including in public uses, publications, or prior patents.
Inventive Step: The invention must not be obvious to a person skilled in the relevant field at the time of filing. The Turkish Patent Office (TPTO) evaluates inventive step based on the prior art available in Turkey and abroad.
Industrial Applicability: The invention must be capable of being used or reproduced in industry, including pharmaceutical manufacturing processes or compositions.
Excluded Subject Matter: The Patent Law excludes methods of surgical, therapeutic, or diagnostic treatment of humans or animals, but the patentability of the product itself, such as a novel biopharmaceutical compound, remains permissible.
What Are the Enforceability Considerations for Biopharmaceutical Patents in Turkey?
Enforceability of biopharmaceutical patents in Turkey hinges on maintaining patent rights through timely and complete filings, proper maintenance, and litigation strategies.
Initial Grant and Opposition: Once granted, third parties can oppose the patent within six months of publication, based on grounds such as lack of novelty or inventive step.
Patent Term: The patent term aligns with international standards—20 years from the filing date. Extensions are generally not available, but data exclusivity can provide additional market protection.
Patent Litigation: Enforcement involves civil procedures. The patent holder must establish infringement through evidence of unauthorized use. The Turkish courts recognize patent rights, and injunctions can be sought to prevent infringing activities.
Validity Challenges: Patents can be nullified if they fail to meet patentability requirements or if they infringe prior rights. Invalidity claims can be filed at any time during patent life but are more common during opposition or litigation.
Data Exclusivity: Data protection rights last for five years, with possible extensions, depending on the pharmaceutical type. This period can delay marketing approvals for generic competitors.
How Broad and Narrow Are the Scope of Claims in Biopharmaceutical Patents in Turkey?
The scope of claims defines the protection conferred by the patent. Turkish patent law emphasizes clear and supported claims, aligned with international standards.
Claim Types: Claims can be product, process, or use claims. In biopharmaceuticals, product claims (covering the compound itself) are most common.
Scope of Product Claims: The scope depends on how specifically the compound is defined. Precise structural formulas, genetic sequences, or functional definitions offer strong protection but can limit scope. Broader claims, such as genus claims, are permissible but face higher scrutiny for inventive step.
Claims in Biotech: Functional or method-based claims must be well supported in the description. Patent examiners scrutinize claims to prevent overly broad coverage that might encompass prior art.
Claim Drafting Strategies: Drafting claims that balance breadth and specificity enhances enforceability. Narrow claims limit infringement risks but may offer limited commercial coverage. Broad claims provide extensive protection but risk invalidation.
Amendments and Limitations: Amendments during prosecution or litigation are allowed but must be supported by the original disclosure. Limiting claims to specific embodiments narrows scope but strengthens defensibility.
Summary of Key Data
| Aspect |
Details |
References |
| Patent term |
20 years from filing |
Law No. 551 (Turkish Patent Law) |
| Opposition period |
6 months post-publication |
Article 96 (Turkish Patent Law) |
| Data exclusivity |
5 years for pharmaceutical products |
Patent and Data Protection Regulations |
| Patentable subject matter |
Products, processes, uses; excludes surgical/therapeutic methods |
Article 3 of the law |
| Novelty standard |
Absolute, requires prior art search in multiple jurisdictions |
Patent Office guidelines |
Key Takeaways
- Patentability depends on demonstrating novelty, inventive step, and industrial applicability, with exclusions for treatment methods.
- Enforceability relies on maintaining rights through timely filings, proper claim drafting, and active litigation strategies.
- Claims should balance broad coverage with specificity to withstand invalidation and enable enforcement.
FAQs
Q1: Can gene sequences be patented in Turkey?
A: Yes. Claims covering specific genetic sequences linked to biopharmaceuticals are allowable if properly supported.
Q2: Are method of treatment claims patentable?
A: No. Turkey excludes methods of surgical, therapeutic, or diagnostic treatment from patent protection.
Q3: How does Turkey handle patent opposition?
A: Oppositions can be filed within six months of patent publication, challenging the patent based on prior art or procedural issues.
Q4: What is the scope difference between specific chemical compounds and genus claims?
A: Specific compounds offer narrower, more defensible protection. Genus claims cover broader classes but face higher scrutiny.
Q5: Does data exclusivity extend the patent term?
A: No. Data exclusivity provides additional market protection duration (five years) but does not extend patent life.
References
- Turkish Patent Law No. 551, 2004.
- Turkish Patent Office Guidelines, 2022.
- TRIPS Agreement, 1994.
- Ankara Intellectual Property Law Journal, 2021.
